Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 hormone that's used in medications like Ozempic.

Daniel Drucker is being recognized for his research on gut hormones in helping develop multiple types of treatments for Type 2 diabetes, obesity and short bowel syndrome.